Deprescribing is a prescribing decision, and papers lose marks when they write it as an absence. The graded version names the drug, states the indication it was started for, shows why that calculation has changed for this body at this age, then supplies the taper, the monitoring and the rule for restarting. Written that way the recommendation reads as active management. Your syllabus, not this manual, determines whether the work goes to a thread, arrives as an uploaded assignment, or does both.
Where this sits among the eleven is a judgment our tutors made about teaching order. No public syllabus exists to check it against and the course guide is closed to anyone without a Walden login, so we say what we think and we label it as ours. A boundary worth repeating: coursework is our product, meaning papers, notes and documentation exercises, and nothing we do reaches a real patient or a signed clinical evaluation.
What a medication paper is marked on
The reconciliation row wants completeness before analysis. Prescriptions from every prescriber, plus the over the counter tablets, the supplements and the eye drops patients rarely think to mention, with a dose and an indication attached to each.
The criteria row wants a published tool used out loud. Naming the criteria set, quoting the reason it flags a particular agent in older adults, and applying that reason to this patient is worth far more than a general remark about caution.
The safety row lives inside the taper. A stop with no schedule, no anticipated withdrawal symptoms and no monitoring plan is the recommendation that loses points even when the drug selected was the right one.
Six moves from a list to a defensible stop
The order our team works in once a medication list runs past a dozen entries.
-
Build one list from every source that writes prescriptions
Cardiology, urology, the walk-in clinic, the dentist and the supermarket shelf all contribute. A list assembled from a single record is a partial list, and the analysis inherits the gap.
-
Attach a living indication to every entry
For each drug write why it is being taken now, not why somebody started it once. Anything you cannot justify in the present tense joins the review list immediately.
-
Look for the cascade before you look at the criteria
A drug prescribed to treat the side effect of another drug is the most rewarding finding in this material, and locating one usually removes two agents rather than one.
-
Apply a named criteria set and show the reasoning
Cite the tool, state which entry it triggers, and explain in a sentence why this patient's age, renal function or comorbidity makes the listed concern real for her specifically.
-
Sequence the withdrawals so each is testable
Stop one agent at a time wherever the situation permits it, leave enough interval to attribute any change, and say which drug goes first and why it was chosen.
-
Write the taper, the monitoring and the restart rule
Doses and dates, the symptoms that would signal withdrawal or relapse, who the patient calls, and the circumstance under which the drug would legitimately return.
A layout for a medication analysis
A working outline from our team. It is not issued by the university, and any section your rubric ignores can be compressed without loss.
| Section | What belongs in it | What the row rewards |
|---|---|---|
| Complete medication list | Every prescribed agent, non-prescription product, supplement, topical and inhaler with dose and frequency. | A list gathered from more than one source, with those sources named. |
| Indication mapping | The current reason for each drug, and a flag on anything without one. | Present-tense indications, with historical ones identified as historical. |
| Cascade and duplication analysis | Agents treating the effects of other agents, and therapeutic duplication across prescribers. | At least one cascade traced from the originating drug to the drug that answered it. |
| Criteria based review | The published criteria applied, the entries triggered, and the patient-specific reasoning. | Criteria cited as a document and reasoned through rather than invoked as authority. |
| Deprescribing plan | Which drug stops first, on what schedule, over what interval, and what is being watched. | A dated sequence in which one variable changes at a time. |
| Patient conversation and follow-up | How the change was explained, what the patient feared, and the review point. | The patient's concern recorded and answered, with a restart rule written down. |
Annotated sample excerpt: a cascade in three drugs
An original excerpt demonstrating what a cascade looks like once it is written down as one.
Mrs A takes an anticholinergic for urinary urgency that began four months after a cholinesterase inhibitor was started for memory complaints, and the two agents pull in opposite directions at the same receptor family.1 A stool softener and a nightly laxative were added across the same period for constipation, which is a predictable effect of the anticholinergic rather than a new bowel disorder, so one questionable prescription is now propped up by three further ones.2 The proposal is therefore to withdraw the anticholinergic first across three weeks, reassess urgency with a two day voiding record before assuming it will return, and hold the laxatives in place until the bowel pattern has been observed for two weeks after that withdrawal finishes.3
- 1The cascade is stated as a pharmacologic conflict rather than as a coincidence of timing, which is what the analysis row is buying.
- 2Two additional prescriptions are traced back to the same source, so the size of the problem is quantified instead of asserted.
- 3The plan carries a duration, a re-measurement and a deliberate decision not to change everything at once.
Give us the medication case and the posted criteria; we draft the opening premium sample at no charge, criteria set applied by name and the taper spelled out.
Five things that drag a medication paper down
- The list transcribed rather than interrogated. A table of drugs with doses and no indication column is data entry, and the analysis rows have nothing at all to score.
- Criteria invoked as a name only. Saying an agent appears on a published list is not an argument until the reason for its listing is applied to this patient.
- Several drugs stopped on the same day. When three things change at once, no symptom afterward can be attributed to any of them, and the paper cannot defend its own monitoring plan.
- Withdrawal effects ignored. Sedatives, acid suppressants, beta blockers and antidepressants all carry rebound or discontinuation phenomena, and predicting them is part of the recommendation.
- The patient left out of the decision. A stop she did not agree to is not a plan, and rows on shared decision making are written precisely to catch a paper that never asked her.
Last look before submission
- The list draws on more than one source and includes non-prescription products
- Every drug has a current indication or an explicit flag
- At least one cascade or duplication is traced and named
- A published criteria set is cited and reasoned through for this patient
- The withdrawal sequence changes one agent at a time with dates attached
- Monitoring, withdrawal symptoms and a restart rule are all written down
Medication analysis due?
Share the case file and the rubric that came attached to it. An original medication analysis takes 24 to 48 hours from us, cascade located, criteria applied by name, taper spelled out, and we revise at no cost until each row scores where it should.